Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot
Code deleted, see 81200-81479

Official Description

Molecular diagnostics; lysis of cells prior to nucleic acid extraction (eg, stool specimens, paraffin embedded tissue), each specimen

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Molecular diagnostics involve a series of tests designed to identify genetic mutations that may indicate the presence of specific diseases, even in patients who do not exhibit any symptoms. These tests play a crucial role in diagnosing current disease states, monitoring ongoing conditions, and screening individuals for genetic predispositions to certain diseases. This can be particularly important for those who may benefit from preventive medical interventions. Prior to conducting molecular testing, it is essential to extract nucleic acids, such as DNA or RNA, from the specimens. The process of lysing cells is a critical step in this extraction, as it involves breaking down the cell walls and membranes using chemical agents. This action allows for the release of nucleic acids contained within the cells, making them available for subsequent analysis. The procedure can be applied to various types of specimens, including stool samples and paraffin-embedded tissues. The CPT® Code 83907 is specifically designated for reporting the lysis of cells prior to nucleic acid extraction for each specimen that undergoes this process.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure of lysing cells prior to nucleic acid extraction is indicated for various scenarios, including:

  • Genetic Testing Molecular diagnostics are performed to detect genetic mutations associated with specific diseases, even in asymptomatic patients.
  • Monitoring Disease States The procedure is utilized to monitor existing disease conditions through the analysis of nucleic acids.
  • Screening for Genetic Carriers It is used to identify individuals who may be carriers of genetic diseases, which can inform family planning and preventive measures.
  • Assessing Predisposition to Conditions The procedure helps in identifying individuals who are genetically predisposed to certain diseases, allowing for early intervention and preventive care.

2. Procedure

The procedure for lysing cells prior to nucleic acid extraction involves several critical steps, which are outlined as follows:

  • Step 1: Specimen Collection The first step involves the careful collection of specimens, which may include stool samples or paraffin-embedded tissues. Proper collection techniques are essential to ensure the integrity of the specimens for subsequent analysis.
  • Step 2: Cell Lysis Once the specimens are collected, the next step is to lyse the cells. This is achieved by applying specific chemical agents that disrupt the cell walls and membranes. The lysis process is crucial as it releases the nucleic acids contained within the cells, making them accessible for extraction.
  • Step 3: Nucleic Acid Extraction After the cells have been lysed, the nucleic acids (DNA or RNA) are extracted from the lysate. This step may involve various techniques and reagents designed to purify the nucleic acids from other cellular components.
  • Step 4: Quality Assessment Following extraction, the quality and quantity of the nucleic acids are assessed to ensure they meet the necessary standards for molecular testing. This may involve using spectrophotometry or gel electrophoresis to evaluate the integrity of the nucleic acids.

3. Post-Procedure

Post-procedure care primarily involves the proper handling and storage of the extracted nucleic acids to maintain their stability for future testing. It is essential to follow specific guidelines for the preservation of these samples, as degradation can occur if they are not stored under appropriate conditions. Additionally, any remaining specimens should be disposed of according to biohazard regulations to ensure safety and compliance with health standards. The results obtained from the molecular diagnostics can then be utilized for further clinical decision-making, including diagnosis, treatment planning, and genetic counseling.

Short Descr LYSE CELLS FOR NUCLEIC EXT
Medium Descr MOLEC DX LYSIS CELLS PRIOR NUCLEIC ACID EXTRTJ
Long Descr Molecular diagnostics; lysis of cells prior to nucleic acid extraction (eg, stool specimens, paraffin embedded tissue), each specimen
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Deleted Code deleted, see 81200-81479
2009-01-01 Changed Code description changed
2006-01-01 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"